183 related articles for article (PubMed ID: 37100923)
1. The Tumor Stemness Indice mRNAsi can Act as Molecular Typing Tool for Lung Adenocarcinoma.
Yi Y; Liu X; Gao H; Qin S; Xu J; Ma F; Guan M
Biochem Genet; 2023 Dec; 61(6):2401-2424. PubMed ID: 37100923
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
3. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
4. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
[TBL] [Abstract][Full Text] [Related]
5. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
[TBL] [Abstract][Full Text] [Related]
6. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
[TBL] [Abstract][Full Text] [Related]
7. Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells.
Wan R; Liao H; Liu J; Zhou L; Yin Y; Mu T; Wei J
Biomed Res Int; 2022; 2022():4404406. PubMed ID: 35480140
[TBL] [Abstract][Full Text] [Related]
8. Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma.
Wang H; Wang Y; Luo W; Zhang X; Cao R; Yang Z; Duan J; Wang K
BMC Pulm Med; 2022 Dec; 22(1):463. PubMed ID: 36471379
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
Zhang H; Cao C; Xiong H
Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
[TBL] [Abstract][Full Text] [Related]
10. mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes.
Wang C; Qin S; Pan W; Shi X; Gao H; Jin P; Xia X; Ma F
Comput Struct Biotechnol J; 2022; 20():2928-2941. PubMed ID: 35765647
[TBL] [Abstract][Full Text] [Related]
11. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer.
Huang K; Wu Y; Xie Y; Huang L; Liu H
Dis Markers; 2021; 2021():4731349. PubMed ID: 34646403
[TBL] [Abstract][Full Text] [Related]
12. Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma.
Yang Q; Zhu W; Gong H
Front Immunol; 2023; 14():1148483. PubMed ID: 37077919
[TBL] [Abstract][Full Text] [Related]
13. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
[TBL] [Abstract][Full Text] [Related]
15. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.
Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C
Front Genet; 2022; 13():860268. PubMed ID: 35464867
[TBL] [Abstract][Full Text] [Related]
16. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma.
Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L
Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Pei J; Wang Y; Li Y
J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
[TBL] [Abstract][Full Text] [Related]
19. Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma.
Shi H; Han L; Zhao J; Wang K; Xu M; Shi J; Dong Z
Cancer Med; 2021 Dec; 10(24):8944-8960. PubMed ID: 34741449
[TBL] [Abstract][Full Text] [Related]
20. Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma.
Han T; Liu Y; Zhou J; Guo J; Xing Y; Xie J; Bai Y; Wu J; Hu D
Sci Rep; 2024 Jan; 14(1):1692. PubMed ID: 38243040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
